Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant-eligible Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02802163
What this trial is testing

Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Early research (Phase 1)UnknownNCT04886206
What this trial is testing

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Not applicableNot Yet RecruitingNCT07332871
What this trial is testing

Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)

Who this might be right for
Heart FailureAtrial FibrillationDefibrillators, Implantable
Yonsei University 120
Testing effectiveness (Phase 2)Ended earlyNCT02295722
What this trial is testing

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

Who this might be right for
Hodgkin's Lymphoma - Relapsed/RefractoryNon-Hodgkin's Lymphoma - AggressiveFollicular Lymphoma
AHS Cancer Control Alberta 100
Large-scale testing (Phase 3)UnknownNCT03720041
What this trial is testing

Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 740
Large-scale testing (Phase 3)Active Not RecruitingNCT04483739
What this trial is testing

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 302
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Testing effectiveness (Phase 2)Study completedNCT00872521
What this trial is testing

Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen-Cilag Pty Ltd 107
Testing effectiveness (Phase 2)Study completedNCT00439465
What this trial is testing

Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
MyelomaTransplant-eligible Patients
Dartmouth-Hitchcock Medical Center 23
Large-scale testing (Phase 3)Study completedNCT01805557
What this trial is testing

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.

Who this might be right for
Diffuse Large B-cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Fondazione Italiana Linfomi - ETS 108
Early research (Phase 1)Active Not RecruitingNCT03572764
What this trial is testing

CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Washington University School of Medicine 20
Testing effectiveness (Phase 2)WithdrawnNCT06348147
What this trial is testing

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Who this might be right for
Newly Diagnosed Multiple MyelomaMultiple MyelomaAutologous Stem Cell Transplantation
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05171335
What this trial is testing

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
The Methodist Hospital Research Institute 50
Testing effectiveness (Phase 2)Study completedNCT02624492
What this trial is testing

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Ended earlyNCT03263767
What this trial is testing

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

Who this might be right for
Graft Versus Host Disease
Nantes University Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT07106684
What this trial is testing

ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02315716
What this trial is testing

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University College, London 281
Not applicableStudy completedNCT00890045
What this trial is testing

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Who this might be right for
Renal Failure Chronic Requiring Hemodialysis
Merit Medical Systems, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT02038933
What this trial is testing

Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

Who this might be right for
Lymphoma. Non-Hodgkin
Bristol-Myers Squibb 121
Next Page